Hasan Akbaba
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advancements in Transdermal Drug Delivery 6
-
- Immunotherapy and Immune Responses 4
- Toxin Mechanisms and Immunotoxins 3
- T-cell and B-cell Immunology 3
- Co-authors
- Gülşah Erel‐Akbaba (18 shared papers)Ayşe Gülten Kantarcı (9 shared papers)Mustafa Kotmakçı (4 shared papers)Bakhos A. Tannous (2 shared papers)Ennio Antonio Chiocca (1 shared paper)Lítia Alves de Carvalho (1 shared paper)Pierre J. Obeid (1 shared paper)Ralph Weissleder (1 shared paper)
- Journals
- Journal of Drug Delivery Science and Technology (3 papers)ACS Omega (2 papers)Scientific Reports (2 papers)Nature Immunology (1 paper)Cell Reports (1 paper)
- Partner nations
- TürkiyeUnited StatesCzechia
In The Last Decade
Hasan Akbaba
37 papers receiving 601 citations
Peers
Comparison fields: 5 of 79
- Pharmaceutical Science 79
- Biomaterials 159
- Immunology 111
- Molecular Medicine 19
- Biomedical Engineering 147
Countries citing papers authored by Hasan Akbaba
This map shows the geographic impact of Hasan Akbaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasan Akbaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasan Akbaba more than expected).
Fields of papers citing papers by Hasan Akbaba
This network shows the impact of papers produced by Hasan Akbaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasan Akbaba. The network helps show where Hasan Akbaba may publish in the future.
Co-authors
The 25 scholars most cited alongside Hasan Akbaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 179 | |
| 2 | 2020 | 88 | |
| 3 | 2016 | 63 | |
| 4 | 2016 | 34 | |
| 5 | 2020 | 30 | |
| 6 | 2020 | 25 | |
| 7 | 2018 | 17 | |
| 8 | 2022 | 14 | |
| 9 | 2016 | 14 | |
| 10 | 1997 | 12 | |
| 11 | 2018 | 11 | |
| 12 | 2022 | 11 | |
| 13 | 2021 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2020 | 9 | |
| 16 | 2018 | 7 | |
| 17 | 2020 | 7 | |
| 18 | 2022 | 7 | |
| 19 | 2023 | 7 | |
| 20 | 2025 | 6 |
About Hasan Akbaba
Hasan Akbaba is a scholar working on Pharmaceutical Science, Immunology, Molecular Biology, Biomaterials and Organic Chemistry, having authored 39 papers that have together received 609 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Advancements in Transdermal Drug Delivery (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Lipid Membrane Structure and Behavior (4 papers), Immunotherapy and Immune Responses (4 papers), Toxin Mechanisms and Immunotoxins (3 papers), T-cell and B-cell Immunology (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). The work is most often cited by research in Pharmaceutical Science (79 citations), Biomaterials (159 citations), Immunology (111 citations), Molecular Medicine (19 citations) and Biomedical Engineering (147 citations). Hasan Akbaba has collaborated with scholars based in Türkiye, United States and Czechia. Frequent co-authors include Gülşah Erel‐Akbaba, Ayşe Gülten Kantarcı, Mustafa Kotmakçı, Bakhos A. Tannous, Ennio Antonio Chiocca, Lítia Alves de Carvalho, Pierre J. Obeid, Ralph Weissleder, Max Zinter and Tian Tian. Their work appears in journals such as Journal of Drug Delivery Science and Technology, ACS Omega, Scientific Reports, Nature Immunology and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.